Results

Total Results: 2,224 records

Showing results for "medication".
Users also searched for: medication reconciliation

101. Let’s Talk About It: Preventing HIV with PrEP (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/hiv-prep-prevention-discussion-guide.pdf
     August 22, 2023 - professional determine your risk for HIV, decide whether taking PrEP is right for you, and discuss which PrEP medication … PrEP (pre-exposure prophylaxis) is a medication that can help prevent you from getting HIV. … 2 Which PrEP medication is best for me? 3 How long does it take for PrEP to be effective? … PrEP Formulations and Medication Adherence There are currently several FDA-approved ways that people

102. Public Comment on Draft Recommendation: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/announcements/public-comment-draft-recommendation-ocular-prophylaxis-gonococcal-ophthalmia-neonatorum
     September 13, 2010 - USPSTF) is inviting public comment on its draft recommendation statement on prophylactic ocular topical medication … recommendation is a reaffirmation of the USPSTF's 2005 recommendation in support of prophylactic ocular topical medication

103. Archived: Evidence Summary: Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/menopausal-hormone-therapy-preventive-medication-december-2017
     December 12, 2017 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions December 12, 2017 Recommendations made by the USPSTF are independen…

104. Final Research Plan: Aspirin to Prevent Cardiovascular Disease: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer
     October 07, 2013 - Cardiovascular Disease Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … history of gastrointestinal bleeding, ulcers, or nonsteroidal anti-inflammatory drug use), or concomitant medication … Comparisons Placebo or no treatment Any active substance or intervention (e.g., nonaspirin medication

105. Archived: Final Research Plan: Aspirin to Prevent Cardiovascular Disease: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
     October 07, 2013 - Cardiovascular Disease Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication … history of gastrointestinal bleeding, ulcers, or nonsteroidal anti-inflammatory drug use), or concomitant medication … Comparisons Placebo or no treatment Any active substance or intervention (e.g., nonaspirin medication

106. Archived: Aspirin Prophylaxis in Pregnancy: Preventive Medication, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-pregnancy-1996
     January 01, 1996 - archived Final Recommendation Statement Aspirin Prophylaxis in Pregnancy: Preventive Medication … Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication … trial, 315 of 919 women failed a 2-week run-in period due to poor compliance with either visits or medication

107. Evidence Summary: Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-adults-interventions
     September 18, 2018 - weight loss interventions, and medication-based weight loss maintenance interventions). … Data from medication trials could not be pooled because of the small number of studies for each medication … Medication and placebo groups both received identical behavioral interventions. … The medication evidence was limited by the small number of trials for each medication, methodological … Weight Loss Results in All Medication-Based Weight Loss and Medication-Based Weight-Loss Maintenance

108. Evidence Summary: Breast Cancer: Medication Use to Reduce Risk | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction
     September 03, 2019 - Share to Email Print Evidence Summary Breast Cancer: Medication … Symptomatic effects (eg, vasomotor, musculoskeletal) varied by medication. … No studies specifically compared shorter vs longer regimens of medication use or initiation based on … Furthermore, no trials directly compared the effects of timing and duration of medication use. … Medication Use for the Risk Reduction of Primary Breast Cancer in Women: A Systematic Review for the

109. Archived: Final Evidence Summary: Falls Prevention in Older Adults: Counseling and Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary24/falls-prevention-in-older-adults-counseling-and-preventive-medication
     December 15, 2010 - archived Final Evidence Summary Falls Prevention in Older Adults: Counseling and Preventive Medication … Medication Assessment and Withdrawal We evaluated 1 small trial (48 participants) of medication assessment … Medication assessment and withdrawal of therapy with medication alone were not associated with a reduced … No harms were reported in the trials evaluating withdrawal of therapy with medication. … Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized,

110. Archived: Final Evidence Review: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review52/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication-2011
     July 15, 2011 - Final Evidence Review Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication … Preventive Services Task Force (USPSTF) recommended prophylactic ocular topical medication for the prevention … neonatorum has become rare in the United States since the implementation of providing universal preventive medication

111. Archived: Final Evidence Summary: Folic Acid to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary25/folic-acid-to-prevent-neural-tube-defects-preventive-medication
     May 15, 2009 - archived Final Evidence Summary Folic Acid to Prevent Neural Tube Defects: Preventive Medication

112. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
     March 15, 2007 - Evidence Summary: Aspirin Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication … by the disorder (that is, colorectal adenoma vs. colorectal cancer), study design, study sample, and medication … respectively), and both used self-reporting of outcomes in mailed questionnaires, as well as mailed medication

113. Archived: Evidence Summary: NSAIDs: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-nsaids/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication
     March 15, 2007 - archived Evidence Summary: NSAIDs Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication … grouped studies by disorder (that is, colorectal adenoma or CRC), study design, study population, and medication

114. Archived: Evidence Summary: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication, 2002 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
     January 15, 2002 - Evidence Summary Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication

115. Final Evidence Review: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
     September 28, 2021 - Evidence Review Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication

116. Final Evidence Review: Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
     August 01, 2023 - Final Evidence Review Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication

117. Draft Evidence Review: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-evidence-review/aspirin-use-to-prevent-preeclampsia-and-related-morbidity-and-mortality-preventive-medication1
     February 23, 2021 - Evidence Review Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication

118. Archived: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
     January 10, 2017 - Final Recommendation Statement Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication … Preventive Medication Folic acid is the synthetic form of folate, a water-soluble B vitamin. … Benefits of Preventive Medication The USPSTF found convincing evidence that folic acid supplementation … Harms of Preventive Medication The USPSTF found adequate evidence that the harms to the mother or infant … benefits of folic acid supplementation differ by dosage or timing. 1 Potential Harms of Preventive Medication

119. Archived: Published Comments and Response: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/published-comments-and-response/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication
     October 15, 2009 - Published Comments and Response Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication

120. Evidence Summary: Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
     January 10, 2017 - Evidence Summary Folic Acid for the Prevention of Neural Tube Defects: Preventive Medication … Page/Document/final-evidence-review146/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication … 4,293 619 4167 0.93 (0.82-1.06) BMI ≥30.0, low dietary folate intake, anticonvulsant medication